Skip to main content
Log in

18F-FDG PET in neurodegenerative Langerhans cell histiocytosis

Results and potential interest for an early diagnosis of the disease

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Introduction

The so called "neurodegenerative Langerhans cell histiocytosis" (ND-LCH) is a rare and severe complication of LCH presenting as a progressive cerebellar ataxia associated with pyramidal tract signs, and cognitive impairment. MRI is the gold standard to investigate CNS lesions of ND-LCH but little is known about functional changes observed in this disease.

Objectives

To search for CNS metabolic changes in NDLCH.

Methods

Seven patients suffering from ND-LCH were investigated by 18F-FDG PET in this prospective study and compared with 21 healthy controls.

Results

ND-LCH patients demonstrated recurrent abnormalities including bilateral hypometabolism in the cerebellum, the basal ganglia (caudate nuclei), frontal cortex and, bilateral, a relatively increased metabolism in the amygdalae (p < 0.001). Functional changes in these anatomical regions may be detected in the absence of any apparent lesion on MRI.

Conclusions

ND-LCH demonstrates a recurrent 18F-FDG PET metabolic signature. Our results suggest that 18F-FDG PET might be a useful tool for an early diagnosis of ND-LCH before neuroradiologic abnormalities appear.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Donadieu J, Rolon MA, Thomas C, et al. (2004) Endocrine involvement in pediatric-onset Langerhans' cell histiocytosis: a population-based study. J Pediatr 144:344–350

    Article  PubMed  Google Scholar 

  2. The French Langerhans' Cell Histiocytosis Study Group (1996) A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. Arch Dis Child 75:17–24

    Google Scholar 

  3. Carpentier MA, Maheut J, Grangeponte MC, Billard C, Santini JJ (1991) Disseminated cerebral histiocytosis X responding to vinblastine therapy: a case report. Brain Dev 13:193–195

    PubMed  CAS  Google Scholar 

  4. Idbaih A, Hoang-Xuan K; Martin-Duverneuil N, Genereau T, Thomas C, Barthez MA, Donadieu J, and The French LCH STUDY GROUP (2004) Langerhans Cell Histiocytosis presenting with progressive cerebellar ataxia: a clinical and neuroradiological study of 13 cases. Neurology 62 (Suppl 5): A196–A197

    Google Scholar 

  5. Martin-Duverneuil N, Idbaih A, Hoang-Xuan K, Donadieu J, Genereau T, Guillevin R, Chiras J, and the French Langerhans Cell Histiocytosis Study Group (2006) MRI features of Neurodegenerative Langerhans Cell Histiocytosis. Eur Radiol 16:2074–2082

    Article  PubMed  CAS  Google Scholar 

  6. Prayer D, Grois N, Prosch H, Gadner H, Barkovich AJ (2004) HMR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis. AJNR Am J Neuroradiol 25:880–891

    PubMed  Google Scholar 

  7. Barthez MA, Araujo E, Donadieu J (2000) Langerhans Cell histiocytosis and the central nervous system in childhood: evolution and prognostic factors. Results of a collaborative study. J Child Neurol 15:150–156

    Article  PubMed  CAS  Google Scholar 

  8. Grois N, Prayer D, Prosch H, Lassmann H (2005) Neuropathology of CNS disease in Langerhans cell histiocytosis. Brain 128:829–838

    Article  PubMed  Google Scholar 

  9. Grois NG, Favara BE, Mostbeck GH, Prayer D (1998) Central nervous system disease in Langerhans cell histiocytosis. Hematol Oncol Clin North Am 12:287–305

    Article  PubMed  CAS  Google Scholar 

  10. Grois N, Barkovich AJ, Rosenau W, Ablin AR (1993) Central nervous system disease associated with Langerhans' cell histiocytosis. Am J Pediatr Hematol Oncol 15:245–254

    Article  PubMed  CAS  Google Scholar 

  11. Wells WM, Viola PV, Atsumi H, Nakajima S, Kikinis R (1996) Multi-modal volume registration by maximization of mutual information. Med Image Anal 1:35–51

    Article  PubMed  Google Scholar 

  12. Pluim JPW, Maintz JBA,Viergever MA (2003) Mutual information based registration of medical images: a survey. IEEE Trans Med Imaging 22:986–1004

    Article  PubMed  Google Scholar 

  13. Calming U, Bemstrand C, Mosskin M, Elander SS, Ingvar M, Henter JI (2002) 18-FDG PET scan in central nervous system Langerhans cell histiocytosis. J Pediatr 141:435–440

    Article  PubMed  Google Scholar 

  14. Birnbaum DC, Shields D, Lippe B, Perlman S, Phillipart M (1989) Idiopathic central diabetes insipidus followed by progressive spastic cerebral ataxia. Report of four cases. Arch Neurol 46:1001–1003

    PubMed  CAS  Google Scholar 

  15. Poe LB, Dubowy RL, Hochhauser L, et al. (1994) Demyelinating and gliotic cerebellar lesions in Langerhans cell histiocytosis. AJNR Am J Neuroradiol 15:1921–1928

    PubMed  CAS  Google Scholar 

  16. Polizzi A, Coghill S, McShane MA, Squier W (2002) Acute ataxia complicating Langerhans cell histiocytosis. Arch Dis Child 86:130–131

    Article  PubMed  CAS  Google Scholar 

  17. Manning L, Sellal F (2003) Hypothalamic amnesia and frontal lobe function disorders after langerhans cell histiocytosis. J Neurol Neurosurg Psychiatry 74:1348

    Article  PubMed  CAS  Google Scholar 

  18. Nanduri VR, Lillywhite L, Chapman C, Parry L, Pritchard J, Vargha-Khadem F (2003) Cognitive outcome of longterm survivors of multisystem langerhans cell histiocytosis: a single-institution, cross-sectional study. J Clin Oncol 21:2961–2967

    Article  PubMed  Google Scholar 

  19. Whitsett SF, Kneppers K, Coppes MJ, Egeler RM (1999) Neuropsychologic deficits in children with Langerhans cell histiocytosis. Med Pediatr Oncol 33:486–492

    Article  PubMed  CAS  Google Scholar 

  20. Otsuka M, Ichiya Y,Kuwabara Y, et al. (1996) Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: a positron emission tomographic study. J Neurol Sci 144:77–83

    Article  PubMed  CAS  Google Scholar 

  21. Foster NL, Gilman S, Berent S, Morin EM, Brown MB, Koeppe RA (1988) Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography. Ann Neurol 24:399–406

    Article  PubMed  CAS  Google Scholar 

  22. Buchler T, Cervinek L, Belohlavek O, et al. (2005) Langerhans cell histiocytosis with central nervous system involvement: Follow-up by FDG-PET during treatment with cladribine. Pediatr Blood Cancer 44:286–288

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M.-J. Ribeiro MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ribeiro, MJ., Idbaih, A., Thomas, C. et al. 18F-FDG PET in neurodegenerative Langerhans cell histiocytosis. J Neurol 255, 575–580 (2008). https://doi.org/10.1007/s00415-008-0751-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-008-0751-8

Key words

Navigation